Sort   by:  
 Page size 
UnknownNew Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis.
Not available
S-EPMC7413024 | biostudies-literature
UnknownIdentification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach.
Not available
S-EPMC9406207 | biostudies-literature
UnknownA multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Not available
S-EPMC6343690 | biostudies-literature
UnknownThe chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Not available
S-EPMC5072993 | biostudies-literature
UnknownCeliac Disease Prevalence is Increased in Primary Sjogren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.
Not available
S-EPMC6517955 | biostudies-literature
UnknownConcomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Not available
S-EPMC10561686 | biostudies-literature
UnknownLoss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
Not available
S-EPMC7731769 | biostudies-literature
UnknownThe prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Not available
S-EPMC8253801 | biostudies-literature
UnknownDistinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476 | biostudies-literature
Sort   by:  
 Page size